ERBB2 (monomer 2)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05de/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05de/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05dd/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05dd/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05dc/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05dc/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05db/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05db/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05da/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05da/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d9/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d9/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d8/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d8/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d7/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d7/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d6/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d6/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d5/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d5/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d4/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d4/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d3/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d3/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d2/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d2/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d1/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d1/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05d0/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05d0/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05cf/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05cf/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05ce/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05ce/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05cd/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05cd/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05cc/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05cc/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05cb/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05cb/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05ca/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05ca/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c9/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c9/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c8/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c8/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c7/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c7/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c6/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c6/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c5/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c5/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c4/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c4/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c3/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c3/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c2/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c2/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c1/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c1/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05c0/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05c0/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05bf/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05bf/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05be/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05be/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05bd/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05bd/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05bc/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05bc/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05bb/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05bb/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05ba/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05ba/erbb2-monomer-2.png"},{"image":"https://icons.biorender.com/w75xh75/5efa4c4e85346400281f05b9/erbb2-monomer-2.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5efa4c4e85346400281f05b9/erbb2-monomer-2.png"}]
Keywords
ERBB2,CD340,Erbb2,ERBB2,HER-2,HER-2/neu,HER2,MLN 19,NEU,NGL,TKR,TKR1,receptor tyrosine kinase,ERBB2,HER2,HER3,ERBB3,CD340